Related Experiment Video

Updated: May 9, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.0K

MMP3 at the crossroads: Linking molecular pathways to disease diagnosis and therapy

Jing Jiang1, Qiong Wu2, Snekha Rajasekaran2

  • 1Section of Cardiology, Department of Medicine, Biological Sciences Division, University of Chicago, Chicago, IL, United States; Binzhou Medical University, Yantai, China.

Pharmacological Research
|May 1, 2025
PubMed

Insights

Matrix metalloproteinase 3 (MMP-3) is crucial for extracellular matrix dynamics and cellular functions. This review explores MMP-3

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Matrix metalloproteinase 3 (MMP-3) is a key enzyme regulating extracellular matrix (ECM) dynamics.
  • MMP-3 influences physiological and pathological processes, including inflammation, cell migration, and proliferation.
  • Emerging roles highlight MMP-3's capacity to activate signaling molecules and interact with cell surface receptors.

Purpose of the Study:

  • To provide a comprehensive overview of MMP-3's molecular regulation, expression, and activity.
  • To discuss MMP-3's involvement in both ECM-dependent and independent pathways across various diseases.
  • To explore MMP-3's potential as a diagnostic and prognostic biomarker and review therapeutic strategies.

Main Methods:

  • Literature review synthesizing current research on MMP-3.
  • Analysis of MMP-3's molecular mechanisms, cellular functions, and disease associations.
  • Evaluation of diagnostic, prognostic, and therapeutic applications of MMP-3.

Main Results:

  • MMP-3 plays a multifaceted role beyond ECM degradation, impacting cellular behaviors and disease progression.
  • MMP-3 is implicated in inflammatory, infectious, cardiovascular, neurodegenerative diseases, and cancer.
  • Evidence supports MMP-3's utility as a biomarker and a target for therapeutic intervention.

Conclusions:

  • MMP-3 is a critical regulator with diverse functions in health and disease.
  • Further research into MMP-3's pathways and clinical applications is warranted.
  • Targeting MMP-3 offers promising therapeutic avenues for various pathological conditions.
Keywords:
CancerCardiovascular diseasesExtracellular matrix (ECM)Infectious diseasesInflammatory diseasesMatrix metalloproteinase 3 (MMP-3)Neurodegenerative diseases

More Related Videos

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

7.4K
Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

341

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.3K